𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cathepsin D immunoreactivity in ovarian cancer: Correlation with prognostic factors

✍ Scribed by Pauline Athanassiadou; Vasiliki Sakellariou; Efthalia Petrakakou; Peter Athanassiades; Cherry Zerva; Anna Liossi; Stylianos Michalas

Publisher
Springer Netherlands
Year
1998
Tongue
English
Weight
645 KB
Volume
4
Category
Article
ISSN
1219-4956

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The prognostic value of tetranectin immu
The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer
✍ Claus K. H⊘gdall; Lise Christensen; Inge Clemmensen πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 795 KB

Background. Tetranectin (TN), a tetrameric, plasminogen-binding protein, was reduced in the plasma of patients with cancer and appears extracellularly in "stimulated" connective tissues, such as the proliferative, connective tissue response to carcinomas known as desmoplasia. Methods. Tissue sample

Ki-67 staining in benign, borderline, ma
Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D
✍ Sonja C. Henzen-Logmans; Elly J. H. Fieret; Els M. J. J. Berns; Maria E. L. van πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 652 KB

Ki-67 immunoreactivity was studied in relation to immunohistochemically assessed expression of epidermal-growth-factor receptor (EGFR), estrogen receptor (ER) progesterone receptor (PgR) and cytosolic levels of cathepsin D in advanced human ovarian adenocarcinomas, borderline and benign cystadenomas

Cathepsin D concentration in primary lar
Cathepsin D concentration in primary laryngeal cancer: Correlation with clinico-pathological parameters, EGFR status and prognosis
✍ Maurizio Maurizi; Giovanni Almadori; Gabriella Cadoni; Giovanni Scambia; Fabrizi πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 493 KB πŸ‘ 2 views

Sixty-three patients with primary laryngeal squamous-cell carcinoma were followed up for a median of 33 months after surgery. Cathepsin D (Cath D) concentration was assayed using a solid phase 2-site immunoradiometric assay in which the first monoclonal antibody (MAb) was coated on the ELISA solid p